USPTO serial 79205802
CELL2SPHERE
Reviewed by CopyMark Law Group
Reg. 5420462Status 709
- Filing date
- Status date
- Registration date
- Mar 13, 2018
- Examiner
- RIEPEL, CHRISTINA MAXINE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELL2SPHERE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
GORDON E R TROY
GORDON E R TROY Gordon E. R. Troy, PCP.O. Box 67Windsor, VT 05089UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for commercial and scientific purposes, other than for medical or veterinary use; biological tissue cultures, cells and cell culture media, other than for medical or veterinary purposes, namely, for scientific and research use; kits for scientific and research use comprised of biological tissue cultures, cells and cell culture media, not for medical or veterinary purposes; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to drug discovery; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to scientific research; kits for scientific and research use comprised primarily of chemical compounds and culture medium for cell culture analysis and also containing plastic laboratory plates | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals, namely, biological tissue cultures and cell cultures for medical or clinical use; pharmaceuticals for use in the fields of oncology and hepatology; pharmaceuticals for the treatment of cancer and hepatic diseases; medical preparations, namely, biological tissue cultures for medical, veterinary and surgical purposes; diagnostic reagents for pharmaceutical, veterinary and medical use; diagnostic preparations for use in the fields of oncology and hepatology for pharmaceutical, veterinary and medical use; diagnostic preparations for the treatment of cancer and hepatic diseases for pharmaceutical, veterinary and medical use; diagnostic biomarker reagents for medical purposes; enzymes for medical and veterinary purposes; biological tissue cultures, living cells, cell culture media for growing cells and stem cells for medical and veterinary purposes; diagnostic cell cultures for medical and veterinary purposes | SECTION 71 - CANCELLED | — |
| 042 | Scientific, technological and design services, namely, technical research and design in the field of new pharmaceuticals; scientific research and development; research and development in the field of microorganisms and cells; scientific and technologic services, namely, industrial analysis and research services in the field of biotechnology and pharmaceuticals; scientific research consulting services relating to cell culture research and development in analytical or therapeutic fields; laboratory consulting services relating to the production of artificial biological tissue in analytical or therapeutic fields; scientific research consulting services relating to the use of biological tissue in analytical or therapeutic research fields; contract research services relating to biotechnology; laboratory research in the field of biotechnology and pharmaceuticals; drug discovery services; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells for diagnostic purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by StemTek Therapeutics SL
- Other trademarks owned by StemTek Therapeutics SL
- Other trademarks owned by StemTek Therapeutics SL
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CELL2SPHERE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 2, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 2, 2025 | INPC | INVALIDATION PROCESSED | — |
| May 27, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 27, 2024 | C71T | CANCELLED SECTION 71 | — |
| Mar 13, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 16, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 10, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 26, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 26, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 13, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 13, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 26, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 22, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 6, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 6, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 6, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 13, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 11, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 3, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 12, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 12, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 8, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 7, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 28, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 28, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 20, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |